Literature DB >> 30334066

Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy.

Ahmed Gawish1, Ahmed Ali Chughtai2, Michael J Eble2.   

Abstract

PURPOSE: To assess the reproducibility of the dose-volume distribution of the initial simulation CT, generated using volumetric modulated arc therapy (VMAT) planning, during the radiotherapy of the prostatic bed based on weekly cone beam CTs (CBCT).
METHODS: Twenty-three patients, after radical prostatectomy were treated with adjuvant or salvage radiotherapy between July and December 2016 and considered for this evaluation. Weekly CBCT scans (n = 138) were imported into the treatment planning system, and the clinical tumor volume (CTV), the rectum and the bladder were contoured. The initially calculated dose distribution and the dose-volume histograms generated from weekly CBCTs were compared. The prostatic fossa dose coverage was assessed by the proportion of the CTV fully encompassed by the 95% and 98% isodose lines. Rectal and bladder volumes receiving 50, 60 and 65 Gy during the treatment were compared to the initial plan, with statistical significance determined using the one-sample t‑test.
RESULTS: Marked variations in the total organ volume of the rectum and the bladder were observed. The correlation between rectum volume and V50 was not significant (p = 0.487), while the bladder volume and V50 demonstrated a significant correlation. There was no correlation between urinary bladder volume and CTV. The change in rectal volume correlated significantly with CTV. The dose coverage (D98% and D95%) to the prostatic bed could be achieved for all patients due to the ventral shift in the volume differences of the rectum.
CONCLUSION: Weekly CBCTs can be considered as adequate verification tools to assess the interfractional variability of the CTV and organs at risk. The proven volume changes in the urinary bladder and the rectum do not compromise the final delivered dose in the CTV.

Entities:  

Keywords:  CBCT; Gastrointestinal toxicity; Genitourinary toxicity; IGRT; Prostate cancer

Mesh:

Year:  2018        PMID: 30334066     DOI: 10.1007/s00066-018-1381-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  38 in total

1.  Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI.

Authors:  A R Padhani; V S Khoo; J Suckling; J E Husband; M O Leach; D P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-06-01       Impact factor: 7.038

2.  Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients.

Authors:  Cesare Cozzarini; Angelo Bolognesi; Giovanni Luca Ceresoli; Claudio Fiorino; Alberto Rossa; Roberto Bertini; Renzo Colombo; Luigi Da Pozzo; Francesco Montorsi; Marco Roscigno; Riccardo Calandrino; Patrizio Rigatti; Eugenio Villa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-01       Impact factor: 7.038

3.  Rectal and bladder motion during conformal radiotherapy after radical prostatectomy.

Authors:  Claudio Fiorino; Franca Foppiano; Paola Franzone; Sara Broggi; Pietro Castellone; Michela Marcenaro; Riccardo Calandrino; Giuseppe Sanguineti
Journal:  Radiother Oncol       Date:  2004-10-28       Impact factor: 6.280

4.  Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.

Authors:  Philip Poortmans; Alberto Bossi; Katia Vandeputte; Mathieu Bosset; Raymond Miralbell; Philippe Maingon; Dirk Boehmer; Tom Budiharto; Zvi Symon; Alfons C M van den Bergh; Christopher Scrase; Hendrik Van Poppel; Michel Bolla
Journal:  Radiother Oncol       Date:  2007-08-13       Impact factor: 6.280

5.  Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.

Authors:  Michel Ghilezan; Di Yan; Jian Liang; David Jaffray; John Wong; Alvaro Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

6.  Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?

Authors:  Richard Choo; George Hruby; Julie Hong; Eugene Hong; Gerrit DeBoer; Cyril Danjoux; Gerard Morton; Laurence Klotz; Edward Bhak; Aileen Flavin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-01       Impact factor: 7.038

7.  Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer.

Authors:  Patrick A Kupelian; Katja M Langen; Omar A Zeidan; Sanford L Meeks; Twyla R Willoughby; Thomas H Wagner; Sam Jeswani; Kenneth J Ruchala; Jason Haimerl; Gustavo H Olivera
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-01       Impact factor: 7.038

8.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).

Authors:  Michel Bolla; Hein van Poppel; Laurence Collette; Paul van Cangh; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Jean-Marie Maréchal; Pierre Scalliet; Karin Haustermans; Marianne Piérart
Journal:  Lancet       Date:  2005 Aug 13-19       Impact factor: 79.321

9.  Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer.

Authors:  Cesare Cozzarini; Claudio Fiorino; Nadia Di Muzio; Filippo Alongi; Sara Broggi; Mauro Cattaneo; Francesco Montorsi; Patrizio Rigatti; Riccardo Calandrino; Ferruccio Fazio
Journal:  Radiother Oncol       Date:  2007-08-13       Impact factor: 6.280

10.  Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.

Authors:  Matthias Guckenberger; Jürgen Meyer; Kurt Baier; Dirk Vordermark; Michael Flentje
Journal:  Radiat Oncol       Date:  2006-09-06       Impact factor: 3.481

View more
  4 in total

1.  Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding.

Authors:  K Braide; J Kindblom; U Lindencrona; J Hugosson; N Pettersson
Journal:  Clin Transl Oncol       Date:  2020-07-03       Impact factor: 3.405

2.  Evaluating the impact of possible interobserver variability in CBCT-based soft-tissue matching using TCP/NTCP models for prostate cancer radiotherapy.

Authors:  Xiangbin Zhang; Xin Wang; Xiaoyu Li; Li Zhou; Shihong Nie; Changhu Li; Xuetao Wang; Guyu Dai; Zhonghua Deng; Renming Zhong
Journal:  Radiat Oncol       Date:  2022-04-01       Impact factor: 3.481

3.  Risk Factors of Acute Radiation-Induced Lung Injury Induced by Radiotherapy for Esophageal Cancer.

Authors:  Faen Zhang; Lihua Liao; Song Wei; Yuqing Lu
Journal:  Comput Math Methods Med       Date:  2022-07-13       Impact factor: 2.809

4.  Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities.

Authors:  Stratos Vassis; Beatrice Nöldeke; Hans Christiansen; Christoph A von Klot; Roland Merten
Journal:  Strahlenther Onkol       Date:  2020-02-10       Impact factor: 3.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.